Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Lipase substrate
Cat. No.:
OB0125LY-057
Appearance:
Powder
Purity:
≥95%
Identity:
Confirmed by HPLC.
Size:
Add to basket
Product Overview
Description:
Lipase substrate is a lipid molecule that is hydrolyzed by lipase.
Synonyms:
195833-46-6; 1,2-Di-O-lauryl-rac-glycero-3-(glutaric acid 6-methylresorufin ester); 1-O-(2,3-Didodecoxypropyl) 5-O-(6-methyl-7-oxophenoxazin-3-yl) pentanedioate; 2,3-Bis(dodecyloxy)propyl 4-methyl-3-oxo-3H-phenoxazin-7-yl pentanedioate
CAS No.:
195833-46-6
Compound CID:
16211907
Formula:
C45H69NO8
Formula Weight:
752.03
Specification
Target:
Lipase
Storage:
Storage at 4°C.
Applications:
Lipase substrate helps to understand diseases associated with lipid metabolism, such as obesity, diabetes and atherosclerosis.
